e-learning
resources
Munich 2006
Monday 04.09.2006
Infections in immunocompromised patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PET‘s importance in chronic pulmonary aspergillosis
G. Schiraldi, F. Blasi, S. Della Patrona, M. Bianchi, L. Allegra (Milan, Italy)
Source:
Annual Congress 2006 - Infections in immunocompromised patients
Session:
Infections in immunocompromised patients
Session type:
Poster Discussion
Number:
3221
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Schiraldi, F. Blasi, S. Della Patrona, M. Bianchi, L. Allegra (Milan, Italy). PET‘s importance in chronic pulmonary aspergillosis. Eur Respir J 2006; 28: Suppl. 50, 3221
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Related content which might interest you:
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 782-800
Year: 2007
Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020
Year: 2021
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Chronic pulmonary aspergillosis in patients with post-tuberculosis bronchiectasis
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation
Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018
Year: 2019
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Predictors of mortality in chronic pulmonary aspergillosis
Source: Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016
Year: 2017
Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Chronic granulomatous disease presenting as pulmonary aspergillosis in a female infant
Source: Eur Respir J 2003; 22: Suppl. 45, 317s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept